AFM
PSTVZ

Anson Funds Management’s PLUS THERAPEUTICS, Inc. Series S Warrant PSTVZ Stock Holding History

Anson Funds Management’s Portfolio PSTVZ Stock Details PSTVZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,038,600
Closed -$3.55M – 97
2019
Q3 		$3.55M Buy
+1,038,600
New +$12.6K 2.61% 7

Other funds holding PSTVZ

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Anson Funds Management's PSTVZ Position: Q4 2019 in Review

Anson Funds Management sold out of PLUS THERAPEUTICS, Inc. Series S Warrant (PSTVZ) in Q4 2019, closing a stake of 1,038,600 shares — an estimated $3.55M sold.

Anson Funds Management first reported a position in PSTVZ in Q3 2019 and held it in 1 quarter. The position peaked at $3.55M in Q3 2019. 6 funds tracked by Wall St. Rank hold PSTVZ as of Q4 2019.

  • Anson Funds Management reported no remaining PLUS THERAPEUTICS, Inc. Series S Warrant position as of Q4 2019 after selling out during the quarter.
  • Anson Funds Management sold 1,038,600 PLUS THERAPEUTICS, Inc. Series S Warrant shares in Q4 2019, an estimated $3.55M.
  • Anson Funds Management first reported a position in PLUS THERAPEUTICS, Inc. Series S Warrant in Q3 2019 and held it in 1 quarter.
  • Anson Funds Management's PLUS THERAPEUTICS, Inc. Series S Warrant position peaked at $3.55M in Q3 2019.
  • 6 funds tracked by Wall St. Rank held PLUS THERAPEUTICS, Inc. Series S Warrant as of Q4 2019.

Based on Anson Funds Management's 13F filing for Q4 2019, filed 14 Feb 2020.